Table 4.
Group Patient satisfaction |
Group(P) (n = 30) |
Group(E) (n = 30) |
Group(D) (n = 30) |
Group(D/E) (n = 30) |
p |
---|---|---|---|---|---|
ExEellent | 9 (30%) | 12(40%) | 11(36.7%) | 21 (63.3%)* | 0.004 |
Good | 9(30%) | 10(33.3%) | 9(30%) | 5(23.3%) | 0.237 |
Fair | 8(26.7%) | 5 (16.5%) | 6(20%) | 2(6.7%) | 0.069 |
Poor | 4(13.3%) | 3(10%) | 3(10%) | 2(6.7%) | 0.933 |
Data are presented as number (%). Data were analyzed using chi square. Placebo group (P), Etoricoxib (E), Duloxetine (D), Duloxetine/Etoricoxib (D/E). P < 0.05 is considered significant
*P = 0.016 when compare with P